Merck KGaA's stock remains a 'hold' due to its high valuation, trading at an earnings multiple of around 20 and a 4.5% free ...

For Maria Rising, managing her health felt like chasing a phantom. The 30-year-old Lansing, Mich. consultant has for years ...

Operator: Good afternoon, and welcome to the Evoke Pharma, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode.

We recently published a list of Friday’s 10 Worst Performing Stocks. In this article, we are going to take a look at where ...

Shares of CVS Group plc (LON:CVSG – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 967.19 ($12.51) and traded as ...

Good afternoon, and welcome to the Evoke Pharma fourth quarter and full-year 2024 earnings conference call. (Operator Instructions) Please be advised that today's call is being recorded. I would now ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...

The contracts, some worth multiple millions of pounds, are to be awarded by council directors, often after tender processes ...

AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...

SS&C’s Eze does have some sensitivity to trading volume—approximately 30% of its Eze revenue (about $300 million) is based on usage. In periods of market turmoil, trading volume tends to increase, ...

Net Product Sales $29.6 Million, Cash Flow from Operations of $11.5 Million Full Year Net Product Sales $120.8 Million, Rolvedon Sales Exceed $60.0 Million Full Year Cash Flow from ...

Inflation drove higher sales at Publix in 2024, but payroll costs and lower pharmacy sales caused a slight drop in operating ...